Lilly to expand Indiana facility with record $5.3bn investment to boost production of APIs
In a historic move for the pharmaceutical industry, Eli Lilly and Company (NYSE: LLY) has announced a staggering $5.3 billion expansion of its Lebanon, Indiana manufacturing site. This investment increases the total commitment to this site to $9 billion, aimed at boosting the production of active pharmaceutical ingredients (API) for Zepbound (tirzepatide) injection and Mounjaro […]
